Novel GLP-1 analogs having improved biological potency as well as extended pharmacological activity are described herein. More specifically, the present invention relates to GLP-1 analogs (28 or 29 aa long) comprising amino acid substitutions at one or more of the following positions: 8, 20, 27, 30 and 33.

 
Web www.patentalert.com

< Treatment for diabetes and obesity as well as method of screening compounds useful for such treatments

> Non-flour containing baked and related food compositions

> Optically active PPAR-activating compound intermediate and method for producing same
~ 00522